TrialBMC nephrology2016

Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial.

Matthew A Roberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.